AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 738.00 Change Price %
High 738.00 1 Day -51.45 -6.93
Low 644.75 1 Week -78.90 -10.24
Close 691.25 1 Month -153.40 -18.16
Volume 10999017 1 Year 174.85 33.86
52 Week High 891.50
52 Week Low 465.00
AUROPHARMA Important Levels
Resistance 2 777.69
Resistance 1 742.07
Pivot 691.33
Support 1 640.43
Support 2 604.81
AUROPHARMA CURRENT MONTH FUTURE
Close 693.35
Contracts Traded 33710
Open Intrest 18955300
Change In O.I 1200500
Lot Size 700
AUROPHARMA CURRENT MONTH OPTION
Most Active Call 760
Most Active put 660
Highest O.I Buildup Call 800
Highest O.I Buildup Put 700
Expiry Date 25-Feb-2016
AUROPHARMA ALL MONTHS OPTIONS
For All AUROPHARMA Options Click Here
NSE INDIA Most Active Stocks
SUZLON 13.60 -9.93%
SBIN 159.00 -4.82%
UNITECH 4.90 -2.00%
SUBEX 10.30 3.52%
PNB 79.95 -8.89%
TATAMOTORS 291.55 -6.15%
NHPC 21.25 2.91%
JPASSOCIAT 7.85 -1.88%
ICICIBANK 207.25 -1.03%
HDIL 66.35 -6.94%
More..
NSE INDIA Top Gainers Stocks
GMBREW 823.75 16.27%
AUSTRAL 0.45 12.50%
GRAVITA 25.15 12.03%
SESHAPAPER 220.35 11.60%
PKTEA 148.30 11.59%
APOLLOTYRE 149.55 10.70%
REIAGROLTD 0.60 9.09%
BILENERGY 1.30 8.33%
MAHABANK 31.90 8.14%
LAKSHMIEFL 18.40 7.92%
More..
NSE INDIA Top Losers Stocks
VISESHINFO 0.10 -33.33%
TECHIN 3.60 -20.00%
CEREBRAINT 16.25 -19.95%
BUTTERFLY 203.00 -18.73%
KSERASERA 0.25 -16.67%
ASHIANA 126.95 -15.95%
HGS 389.55 -14.63%
JCTEL 0.30 -14.29%
SHREYANIND 32.60 -14.10%
OISL 9.10 -13.74%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 4
As on 10th Feb 2016 AUROPHARMA Share Price closed @ 691.25 and we RECOMMEND Sell for LONG-TERM with Stoploss of 738.19 & Strong Sell for SHORT-TERM with Stoploss of 819.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for February
1st Target up-side 899.54
2nd Target up-side 945.3
3rd Target up-side 991.07
1st Target down-side 768.96
2nd Target down-side 723.2
3rd Target down-side 677.43
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 30.54 Sideways
MFI (14) MFI is 22.69 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is -75.94 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 801.71
10 Day Avg Volume Traded 191.64 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.